Skip to content
zameds

Dermoban

Mupirocin

No structure available

This product's active ingredient could not be matched to a single known compound.

Registration

Applicants
1
Registrations
1

Applicants and registrations

ApplicantBrandsDosagesRegistrationsScheduleLeaflets
Unicorn Pharmaceuticals (Pty) LtdDermoban20 mg440972Not determinedPIPIL

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Dermoban ointment

EACH 1,0 g OINTMENT CONTAINS MUPIROCIN 20,0 mg

20 mgOintments.44097244/20.1.6/0972Approved 13 February 2025RegisteredNot determinedPIPIL

Regulatory status

This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.

Listings for this ingredient that could not be applied to this product

  • S4: Mupirocin

    • except when intended for topical application to the epidermis, nares and external ear.

    Consolidated Schedules 06 July 2026, line 7193

  • S2: Mupirocin

    • when intended for application to the skin, nares and external ear.

    Consolidated Schedules 06 July 2026, line 2359

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

Background

Loading...
Loading Wikipedia summary

SAHPRA documents

Professional information (PI)For healthcare professionalsDermoban ointment, Unicorn Pharmaceuticals (Pty) LtdPatient information leaflet (PIL)For patients and carersDermoban ointment, Unicorn Pharmaceuticals (Pty) Ltd

These documents come from SAHPRA's PI-PIL repository unless the line under a document says otherwise. Always consult with a healthcare professional for medical advice.

Research articles

Loading...
Loading PubMed articles